论文部分内容阅读
选取92例老年慢性心力衰竭患者按随机数字表法分成研究组和对照组各46例。对照组实行常规治疗,研究组在常规治疗的同时采用卡维地洛联合螺内酯进行治疗。对比两组治疗效果、不良反应发生率及治疗前、后心功能。研究组治疗的总有效率高于对照组(P<0.05);两组不良反应发生率无明显差异(P>0.05);两组治疗前心功能无明显差别(P>0.05);研究组治疗后心功能优于对照组(P<0.05)。卡维地洛联合螺内酯可有效地提高对老年慢性心力衰竭的治疗效果,并促进患者心功能的改善。
Ninety-two elderly patients with chronic heart failure were randomly divided into study group and control group according to random number table. The control group received routine treatment. The study group was treated with carvedilol combined with spironolactone during routine treatment. Compare the two groups of treatment effect, the incidence of adverse reactions and heart function before and after treatment. The total effective rate of the treatment group was higher than that of the control group (P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). There was no significant difference between the two groups before treatment (P> 0.05) After heart function better than the control group (P <0.05). Carvedilol combined with spironolactone can effectively improve the treatment of senile chronic heart failure, and improve the patient’s cardiac function.